Barely Significant
← all excerpts

Efficacy of targeted agents in the treatment of elderly patients with advanced non-small-cell lung cancer: a systematic review and meta-analysis.

Onco Targets Ther · 2016 · PMC4976916 · PMID 27536143

Europe PMCDOI
1
hedged sentence
0.0600
closest p · 1.2× alpha
0.0600
boldest claim

The sentences

marginally significantP =0.06so close (0.05 < p ≤ 0.1)
Additionally, we performed subgroup analysis according to specific TAs and found that the use of anti-VEGF agents significantly improved PFS (HR 0.81, 95% CI: 0.69–0.96, P =0.012) and a marginally significant PFS benefits for anti-EGFR agents (HR 0.89, 95% CI: 0.79–1.01, P =0.06).

also in 26,082 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.